AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

The company is also raising its full-year guidance to $14.9 billion in adjusted EBITDA, an 8.8% increase from its last ...

UK-based biopharmaceutical company AstraZeneca has announced a $3.5bn investment to expand its research and manufacturing ...

Absci Corp. ( (ABSI) ) has released its Q3 earnings. Here is a breakdown of the information Absci Corp. presented to its investors. Absci ...

Home Depot Inc (NYSE: HD) (Q3) EPS of $3.64, compared to $3.81 in the prior-year quarter. AstraZeneca plc (NASDAQ: AZN) (Q3) EPS of $1.01, compared to 87 cents in the prior-year quarter. Shopify Inc ...

BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p18,000.00. Justin Smith has given his Buy rating due to a combination of ...

AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion ...

All 11 sectors are in the green for the year. The optimism comes as the economy is likely to continue to grow because the ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18,267.00 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

Analysts at Williams Trading and BTIG have upgraded their ratings for On Holding AG (ONON) to Buy from Hold/Neutral, ...

Former Democratic congresswoman Tulsi Gabbard has been appointed as the director of national intelligence by US President-elect Donald Trump. Gabbard, who switched to the Republican Party, is a ...